Pernod Ricard (RI) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
3 Feb, 2026Executive summary
Q1 FY26 net sales reached €2,384m, down 7.6% organically and 14.3% reported, mainly due to declines in China and the USA, with negative FX and perimeter impacts.
U.S. sales fell 16% due to inventory adjustments and subdued market, while China contracted 27% amid weak consumer sentiment, regulatory impacts, and inventory adjustments.
India showed strong underlying growth except in Maharashtra, where excise policy changes dampened demand.
Global travel retail sales dropped 15–16%, with recovery expected from Q2 as cognac sales in China duty-free resume.
Positive sales momentum noted in Canada, Turkey, Japan, and South Africa, partially offsetting declines in key markets.
Financial highlights
Reported sales declined 14%, with a negative FX impact of €143 million and a perimeter impact of €54 million from brand and wine disposals.
Americas sales declined 12% organically; Asia/Rest of World down 7%; Europe down 4%.
Price mix was negatively impacted by market mix, and volumes declined in key markets.
U.S. sell-out performance improved, narrowing the gap to market to 2-3 points, with Jameson, Absolut, and Kahlúa outperforming competitors.
India net sales grew 3%, but would have been +7% excluding Maharashtra's excise impact.
Outlook and guidance
Expectation for improving organic net sales trends in H2, driven by easier comps in China, resumption of China duty-free sales, and dynamic India performance.
Full-year guidance unchanged, with anticipated organic net sales growth of 3–6% per annum in the medium term and annual operating margin expansion.
Operational efficiency program targeting €1 billion in savings by FY2029 to support margin defense.
Cash generation remains a focus, with CapEx and strategic inventory investments below €900 million for FY2026.
A&P investment ratio to remain at ~16%; focus on strict cost control.
Latest events from Pernod Ricard
- Sales and profit fell, but free cash flow improved and medium-term growth targets reaffirmed.RI
H1 202619 Feb 2026 - Organic sales down 1%, margins up, net profit down 35%, FY25 growth expected.RI
H2 202423 Jan 2026 - Q1 sales declined 5.9% organically, with China and US driving the downturn; guidance unchanged.RI
Q1 202519 Jan 2026 - Stable sales, margin gains, and a €4.70 dividend headline a governance-focused AGM.RI
AGM 202415 Jan 2026 - Margin and cash flow improved despite sales and profit declines amid FX and China headwinds.RI
H1 20259 Jan 2026 - Resilient results, stable dividends, and all resolutions approved amid global challenges.RI
AGM 202527 Dec 2025 - Q3 FY25 organic net sales fell 3%, but FY25 outlook and €2.35 dividend were confirmed.RI
Q3 202521 Dec 2025 - Organic sales fell 3% but margin and cash flow improved; FY26 to be a transition year.RI
H2 202523 Nov 2025 - Sharpened pricing, focused portfolio, and stronger wholesaler ties drive renewed brand momentum.RI
Investor Update18 Nov 2025